About Editorial team of BIPNs

Main team of content of bipns.com. Any type of content should be approved by us.
27 11, 2025

Application of green tea to enhance the antioxidant properties of fermented cauliflower

By |2025-11-27T09:47:10+02:00November 27, 2025|Dietary Supplements News, News|0 Comments


  • Jarmoluk, A. Food technology. T.1. Raw materials, products, functional food (in Polish) (Educational Publishing House WSiP, 2016).

  • Engel, E., Baty, C., Le Corre, D., Souchon, I. & Martin, N. Flavor-active compounds potentially implicated in cooked cauliflower acceptance. J. Agric. Food Chem. 50, 6459–6467. https://doi.org/10.1021/jf025579u (2002).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Bell, L., Oloyede, O. O., Lignou, S., Wagstaff, C. & Methven, L. Taste and flavor perceptions of glucosinolates, isothiocyanates, and related compounds. Mol. Nutr. Food Res. 62, 1700990. https://doi.org/10.1002/mnfr.201700990 (2018).

    Article 
    CAS 

    Google Scholar
     

  • Wieczorek, M. N. et al. The relation between phytochemical composition and sensory traits of selected Brassica vegetables. LWT 156, 113028. https://doi.org/10.1016/j.lwt.2021.113028 (2022).

    Article 
    CAS 

    Google Scholar
     

  • Thompson, H. O., Önning, G., Holmgren, K., Strandler, H. S. & Hultberg, M. Fermentation of cauliflower and white beans with Lactobacillus plantarum—Impact on levels of riboflavin, folate, vitamin B12, and amino acid composition. Plant Foods Hum. Nutr. 75, 236–242. https://doi.org/10.1007/s11130-020-00806-2 (2020).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Jastrzębska, A. et al. Determination of selected biogenic amines in fermented vegetables juices. Food Control 154, 109980. https://doi.org/10.1016/j.foodcont.2023.109980 (2023).

    Article 
    CAS 

    Google Scholar
     

  • Paramithiotis, S., Hondrodimou, O. L. & Drosinos, E. H. Development of the microbial community during spontaneous cauliflower fermentation. Food Res. Int. 43, 1098–1103. https://doi.org/10.1016/j.foodres.2010.01.023 (2010).

    Article 
    CAS 

    Google Scholar
     

  • Rachwał, K., Gustaw, K. & Sadok, I. Enhancing food sustainability through probiotics isolated from fermented cauliflower. Sustainability 16, 8340. https://doi.org/10.3390/su16198340 (2024).

    Article 
    ADS 
    CAS 

    Google Scholar
     

  • Herman, A., Matulewicz, O., Korzeniowska, E. & Herman, A. P. Determination of post-fermentation waste from fermented vegetables as potential substitutes for preservatives in o/w emulsion. Int. J. Mol. Sci. 25, 5510. https://doi.org/10.3390/ijms25105510 (2024).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Xu, H., Wu, H., Zhou, R., Yu, F. & Zang, R. The effects of fermented cauliflower residue feed on the diarrhea rate, intestinal morphology, immune indicators, and intestinal flora of weaned piglets. Fermentation 10, 465. https://doi.org/10.3390/fermentation10090465 (2024).

    Article 
    CAS 

    Google Scholar
     

  • Wojdyła, T. & Wichrowska, D. The influence of additives used and storage methods on the quality of sauerkraut. Inż. Ap. Chem. 53, 424–426 (2014).


    Google Scholar
     

  • Choi, W.-Y. & Park, K.-Y. Increased preservative and antimutagenic activities of kimchi with addition of green tea leaves. J. Food Sci. Nat. 5, 189–193 (2000).


    Google Scholar
     

  • Patent KR100384309B1. Functional Kimchi added green tea and process for preparation thereof (Korea, 2003).

  • Patent KR20170025806A. Kimchi Composition Comprising Vitamin C and Its Antioxidative Activity and Whitening Effect (Korea, 2017).

  • Musial, C., Kuban-Jankowska, A. & Gorska-Ponikowska, M. Beneficial properties of green tea catechins. Int. J. Mol. Sci. 21, 1744. https://doi.org/10.3390/ijms21051744 (2020).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Cichoń, Z., Miśniakiewicz, M. & Szkudlarek, E. Properties of green tea (in Polish). Zesz. Nauk. 73, 59–90 (2007).


    Google Scholar
     

  • Kodama, D. H., Goncalves, A. E. S. S., Lajolo, F. M. & Genovese, M. I. Flavonoids, total phenolics and antioxidant capacity: Comparison between commercial green tea preparations. Ciênc. Tecnol. Aliment. Camp. 30, 1077–1082. https://doi.org/10.1590/S0101-20612010000400037 (2010).

    Article 

    Google Scholar
     

  • Luo, Q. et al. Green extraction of antioxidant polyphenols from green tea (Camellia sinensis). Antioxidants 9, 785. https://doi.org/10.3390/antiox9090785 (2020).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Narukawa, M. et al. Evaluation of the bitterness of green tea catechins by a cell-based assay with the human bitter taste receptor hTAS2R39. Biochem. Biophys. Res. Commun. 405, 620–625. https://doi.org/10.1016/j.bbrc.2011.01.079 (2011).

    Article 
    ADS 
    CAS 
    PubMed 

    Google Scholar
     

  • Han, T. & Aye, K. N. The legend of laphet: A Myanmar fermented tea leaf. J. Ethn. Foods 2, 173–178. https://doi.org/10.1016/j.jef.2015.11.003 (2015).

    Article 

    Google Scholar
     

  • Cao, L. T. et al. A comparative analysis for the volatile compounds of various Chinese dark teas using combinatory metabolomics and fungal solid-state fermentation. J. Food Drug Anal. 26, 112–123. https://doi.org/10.1016/j.jfda.2016.11.020 (2018).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zhao, Z.-J. et al. Flavour chemical dynamics during fermentation of kombucha tea. EJFA 30, 732–741. https://doi.org/10.9755/ejfa.2018.v30.i9.1794 (2018).

    Article 

    Google Scholar
     

  • Cheng, L. et al. Distinct changes of metabolic profile and sensory quality during Qingzhuan tea processing revealed by LC-MS-Based metabolomics. J. Agri. Food Chem. 68, 4955–4965. https://doi.org/10.1021/acs.jafc.0c00581 (2020).

    Article 
    ADS 
    CAS 

    Google Scholar
     

  • Wang, R., Sun, J. C., Lassabliere, B., Yu, B. & Liu, S. Q. UPLC-Q-TOF-MS based metabolomics and chemometric analyses for green tea fermented with Saccharomyces boulardii CNCM I-745 and Lactiplantibacillus plantarum 299V. Curr. Res. Food Sci. 5, 471–478. https://doi.org/10.1016/j.crfs.2022.02.012 (2022).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bogdański, P. et al. Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients. Nutr. Res. 32, 421–427. https://doi.org/10.1016/j.nutres.2012.05.007 (2012).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Indarti, K., Apriani, E. F., Wibowo, A. E. & Simanjuntak, P. Antioxidant activity of ethanolic extract and various fractions from green tea (Camellia sinensis L.) leaves. Pharmacog. J. 11, 771–776. https://doi.org/10.5530/pj.2019.11.122 (2019).

    Article 
    CAS 

    Google Scholar
     

  • Xu, X. Y. et al. Effects and mechanisms of tea for the prevention and management of cancers: An updated review. Crit. Rev. Food Sci. Nutr. 60, 1693–1705. https://doi.org/10.1080/10408398.2019.1588223 (2020).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Hirose, K. et al. Preparing and characterizing of xyloglucan films containing tea extract for oral mucositis. ACS Omega 10, 390–399. https://doi.org/10.1021/acsomega.4c06410 (2025).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Liu, S., Zhang, Q., Li, H., Qiu, Z. & Yu, Y. Comparative assessment of the antibacterial efficacies and mechanisms of different tea extracts. Foods 11, 620. https://doi.org/10.3390/foods11040620 (2022).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Alkufeidy, R. M., Altuwijri, L. A., Aldosari, N. S., Alsakabi, N. & Dawoud, T. M. Antimicrobial and synergistic properties of green tea catechins against microbial pathogens. J. King Saud Univ. Sci. 36, 103277. https://doi.org/10.1016/j.jksus.2024.103277 (2024).

    Article 

    Google Scholar
     

  • Parvez, Md. A. K. et al. Antibacterial activities of green tea crude extracts and synergistic effects of epigallocatechingallate (EGCG) with gentamicin against MDR pathogens. Heliyon 5, e02126. https://doi.org/10.1016/j.heliyon.2019.e02126 (2019).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kováć, J., Slobodníková, L., Nebus, B. & Kurin, E. Antibacterial activity of green tea and peppermint extracts against Enterococcus faecalis and the potential of EGCG in oral health. Eur. Pharm. J. 2025, 1–7. https://doi.org/10.2478/afpuc-2025-0002 (2025).

    Article 
    CAS 

    Google Scholar
     

  • McCue, P. P. & Shetty, K. Phenolic antioxidant mobilization during yogurt production from soymilk using Kefir cultures. Process Biochem. 40, 1791–1797 (2005).

    Article 
    CAS 

    Google Scholar
     

  • Lee, H. C., Jenner, A. M., Low, C. S. & Lee, Y. K. Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. Res. Microbiol. 157, 876–884 (2006).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Jaziri, I., Ben Slama, M., Mhadhbi, H., Urdaci, M. C. & Hamdi, M. Effect of green and black teas (Camellia sinensis L.) on the characteristic microflora of yogurt during fermentation and refrigerated storage. Food Chem. 112, 614–620 (2009).

    Article 
    CAS 

    Google Scholar
     

  • Neffe-Skocińska, K., Jaworska, D., Kołożyn-Krajewska, D., Dolatowski, Z. & Jachacz-Jówko, L. The effect of LAB as probiotic starter culture and green tea extract addition on dry fermented pork loins quality. Biomed. Res. Int. 19, 452757. https://doi.org/10.1155/2015/452757 (2015).

    Article 
    CAS 

    Google Scholar
     

  • Jin, Y. H. et al. Lactic acid fermented green tea with Levilactobacillus brevis capable of producing γ-aminobutyric acid. Fermentation 7, 110. https://doi.org/10.3390/fermentation7030110 (2021).

    Article 
    CAS 

    Google Scholar
     

  • Wang, R., Sun, J., Lassabliere, B., Yu, B. & Liu, S. Green tea fermentation with Saccharomyces boulardii CNCM I-745 and Lactiplantibacillus plantarum 299V. LWT 157, 113081. https://doi.org/10.1016/j.lwt.2022.113081 (2024).

    Article 
    CAS 

    Google Scholar
     

  • Nguyen, N. K., Dong, N. T., Nguyen, H. & Le, P. H. Lactic acid bacteria: Promising supplements for enhancing the biological activities of Kombucha. Springer Plus 4, 91. https://doi.org/10.1186/s40064-015-0872-3 (2015).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Xia, X.-X., Wang, B. & Fang, F. Enhancement of Kombucha fermentation by adding lactic acid bacteria. Food Ferment. Ind. 44, 185–192. https://doi.org/10.13995/j.cnki.11-1802/ts.017688 (2018).

    Article 

    Google Scholar
     

  • Zhuang, X. et al. Fermentation quality of herbal tea residue and its application in fattening cattle under heat stress. BMC Vet. Res. 17, 348. https://doi.org/10.1186/s12917-021-03061-y (2021).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Chen, X., Zhou, X., Li, S., Zhang, H. & Liu., Z.,. Effects of tea residues-fermented feed on production performance, egg quality, antioxidant capacity, caecal microbiota, and ammonia emissions of laying hens. Front. Vet. Sci. 10, 1195074. https://doi.org/10.3389/fvets.2023.1195074 (2023).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Hong, G.-H., Lee, S.-Y., Yoo, J.-I., Chung, J. H. & Park, K.-Y. Catechin with lactic acid bacteria starters enhances the antiobesity effect of kimchi. J. Med. Food 26, 560–569. https://doi.org/10.1089/jmf.2023.K.0067 (2023).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Hong, G.-H., Lee, S.-Y. & Park, K.-Y. Antiobesity effect and metabolite analysis of catechin functional kimchi. J. Ethn. Foods 11, 32. https://doi.org/10.1186/s42779-024-00248-0 (2024).

    Article 

    Google Scholar
     

  • Hayashi, T., Ueda, S., Suruta, H. T., Kuwahara, H. & Osawa, R. Complexing of green tea Catechins with food constituents and degradation of the complexes by Lactobacillus plantarum. BMFH 31, 27–36. https://doi.org/10.12938/bmfh.31.27 (2012).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Tarrah, A. et al. Probiotic potential and biofilm inhibitory activity of Lactobacillus casei group strains isolated from infant feces. J. Funct. Foods 54, 489–497. https://doi.org/10.1016/j.jff.2019.02.004 (2019).

    Article 
    CAS 

    Google Scholar
     

  • Tumbarski, Y. et al. Characterization and selection of Lactobacillus strains with potential probiotic applications. Appl. Sci. 15, 2902. https://doi.org/10.3390/app15062902 (2025).

    Article 
    CAS 

    Google Scholar
     

  • Anumudu, C. K., Miri, T. & Onyeaka, H. Multifunctional applications of lactic acid bacteria: Enhancing safety, quality, and nutritional value in foods and fermented beverages. Foods 13, 3714. https://doi.org/10.3390/foods13233714 (2024).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bangar, S. P., Suri, S., Trif, M. & Ozogul, F. Organic acids production from lactic acid bacteria: A preservation approach. Food Biosci. 46, 101615. https://doi.org/10.1016/j.fbio.2022.101615 (2022).

    Article 
    CAS 

    Google Scholar
     

  • Ravyts, F., Vuyst, L. D. & Leroy, F. Bacterial diversity and functionalities in food fermentations. Eng. Life Sci. 12, 356–367. https://doi.org/10.1002/elsc.201100119 (2012).

    Article 
    CAS 

    Google Scholar
     

  • Zielinski, H., Surma, M. & Zielinska, D. The naturally fermented sour pickled cucumbers. In Fermented Foods in Health and Disease Prevention (eds Frias, J. et al.) 503–516 (Academic Press, Cambridge, 2017).

    Chapter 

    Google Scholar
     

  • Daba, G. M., Elnahas, M. O. & Elkhateeb, W. A. Contributions of exopolysaccharides from lactic acid bacteria as biotechnological tools in food, pharmaceutical, and medical applications. Int. J. Biol. Macromol. 173, 79–89. https://doi.org/10.1016/j.ijbiomac.2021.01.110 (2021).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Korcz, E. & Varga, L. Exopolysaccharides from lactic acid bacteria: Techno-functional application in the food industry. Trends Food Sci. Technol. 110, 375–384. https://doi.org/10.1016/j.tifs.2021.02.014 (2021).

    Article 
    CAS 

    Google Scholar
     

  • Kuria, M. W., Matofari, J. W. & Nduko, J. M. Physicochemical, antioxidant, and sensory properties of functional mango (Mangifera indica L.) leather fermented by lactic acid bacteria. J. Agric. Food Res. 6, 100206. https://doi.org/10.1016/j.jafr.2021.100206 (2021).

    Article 
    CAS 

    Google Scholar
     

  • Quan, Q., Liu, W., Guo, J., Ye, M. & Zhang, J. Effect of six lactic acid bacteria strains on physicochemical characteristics, antioxidant activities and sensory properties of fermented orange juices. Foods 11, 1920. https://doi.org/10.3390/foods11131920 (2022).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Xu, H. et al. Change of phytochemicals and bioactive substances in Lactobacillus fermented Citrus juice during the fermentation process. LWT 180, 114715. https://doi.org/10.1016/j.lwt.2023.114715 (2023).

    Article 
    CAS 

    Google Scholar
     

  • Jayashree, S., Jayaraman, K. & Kalaichelvan, G. Isolation, screening and characterization of riboflavin producting lactic acid bacteria from Katpadi Vellore district. Recent Res. Sci. Technol. 2, 83–88 (2010).


    Google Scholar
     

  • Capozzi, V. et al. Biotechnological production of vitamin B2-enriched bread and pasta. J. Agric. Food Chem. 59, 8013–8020. https://doi.org/10.1021/jf201519h (2011).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Santos, F., Wegkamp, A., de Vos, W. M., Smid, E. J. & Hugenholtz, J. High-level folate production in fermented foods by the B12 producer Lactobacillus reuteri JCM1112. Appl. Environ. Microbiol. 74, 3291–3294. https://doi.org/10.1128/AEM.02719-07 (2008).

    Article 
    ADS 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • LeBlanc, J. G., Taranto, M. P., Molina, V. & Sesma, F. B-group vitamins production by probiotic lactic acid bacteria in Biotechnology of Lactic Acid Bacteria: Novel Applications (eds. Mozzi, F., Raya, R., Vignolo G.) 211–232 (Wiley-Blackwell 2010).

  • Torres, A. C. et al. Cobalamin production by Lactobacillus coryniformis: Biochemical identification of the synthetized corrinoid and genomic analysis of the biosynthetic cluster. BMC Microbiol. 16, 240. https://doi.org/10.1186/s12866-016-0854-9 (2016).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Li, P., Gu, Q., Yang, L., Yu, Y. & Wang, Y. Characterization of extracellular vitamin B12 producing Lactobacillus plantarum strains and assessment of the probiotic potentials. Food Chem. 234, 494–501. https://doi.org/10.1016/j.foodchem.2017.05.037 (2017).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Singh, B. & Sharma, S. Vitamin B12 production by Lactobacillus species isolated from milk products. J. Res. Appl. Sci. Biotechnol. 1, 48–59. https://doi.org/10.55544/jrasb.1.2.6 (2022).

    Article 

    Google Scholar
     

  • Morishita, T., Tamura, N., Makino, T. & Kudo, S. Production of menaquinones by lactic acid bacteria. J. Dairy Sci. 82, 1897–1903 (1999).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Boe, C. A. & Holo, H. Engineering Lactococcus lactis for Increased Vitamin K2 Production. Front Bioeng. Biotechnol. 8, 191. https://doi.org/10.3389/fbioe.2020.00191 (2020).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Behera, S. S., Ray, R. C. & Zdolec, N. Lactobacillus plantarum with functional properties: an approach to increase safety and shelf-life of fermented foods. BioMed. Res. Int. 2018, 9361614. https://doi.org/10.1155/2018/9361614 (2018).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Tang, H., Huang, W. & Yao, Y.-F. The metabolites of lactic acid bacteria: classification, biosynthesis and modulation of gut microbiota. Microbial Cell 10, 49–62. https://doi.org/10.15698/mic2023.03.792 (2023).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Knez, E., Kadac-Czapska, K. & Grembecka, M. Fermented vegetables and legumes vs lifestyle diseases: microbiota and more. Life 13, 1044. https://doi.org/10.3390/life13041044 (2023).

    Article 
    ADS 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Shah, A. M., Tarfeen, N., Mohamed, H. & Song, Y. Fermented foods: Their health-promoting components and potential effects on gut microbiota. Fermentation 9, 118. https://doi.org/10.3390/fermentation9020118 (2023).

    Article 
    CAS 

    Google Scholar
     

  • Todorovic, S. et al. Health benefits and risks of fermented foods—the PIMENTO initiative. Front. Nutr. 11, 1458536. https://doi.org/10.3389/fnut.2024.1458536 (2024).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • AOAC. Official Method of Analysis, 18th ed. (Association of Officiating Analytical Chemists, 2015).

  • Krełowska-Kułas, M. Analyses of Food Products Quality (in polish) (PWE, 1993).

  • Turkmen, N., Sari, F. & Velioglu, Y. S. The effect of cooking methods on total phenolics and antioxidant activity of selected green vegetables. Food Chem. 93, 713–718. https://doi.org/10.1016/j.foodchem.2004.12.038 (2005).

    Article 
    CAS 

    Google Scholar
     

  • Shraim, A. M., Ahmed, T. A., Rahman, M. M. & Hijji, Y. M. Determination of total flavonoid content by aluminum chloride assay: A critical evaluation. LWT 150, 111932. https://doi.org/10.1016/j.lwt.2021.111932 (2021).

    Article 
    CAS 

    Google Scholar
     

  • Brand-Williams, W., Cuvelier, M. E. & Berset, C. Use of a free radical method to evaluate antioxidant activity. LWT 28, 25–30. https://doi.org/10.1016/S0023-6438(95)80008-5 (1995).

    Article 
    CAS 

    Google Scholar
     

  • Re, R. et al. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic. Biol. Med. 26, 1231–1237. https://doi.org/10.1016/S0891-5849(98)00315-3 (1999).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Benzie, I. F. F. & Strain, J. J. The ferric reducing ability of plasma (FRAP) as a measure of ‘Antioxidant Power’: The FRAP Assay. Anal. Biochem. 239, 70–76. https://doi.org/10.1006/abio.1996.0292 (1996).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • PN-EN ISO 8586:2014-03 Sensory analysis. General guidelines for the selection, training, and monitoring of selected assessors and sensory evaluation experts. Polish Committee for Standardization.

  • PN-ISO 5496:1997 Sensory analysis. Methodology. Introduction and training of assessors in the detection and recognition of odors. Polish Committee for Standardization.

  • PN-ISO 3972:2016-07 Sensory analysis. Methodology. Methods for testing taste sensitivity. Polish Committee for Standardization

  • PN-EN ISO 11132:2017-08 Sensory analysis. Methodology. Guidelines for monitoring the performance of a quantitative sensory system. Polish Committee for Standardization.

  • PN-EN ISO 8589:2010 Sensory analysis. General guidelines for the design of sensory analysis laboratories. Polish Committee for Standardization.

  • PN-ISO 5497:1998 Sensory analysis. Methodology. Guidelines for the preparation of samples for which direct sensory analysis is not possible. Polish Committee for Standardization.

  • PN-ISO 11035:1999 Sensory analysis. Identification and selection of descriptors for determining the sensory profile using multivariate methods. Polish Committee for Standardization.

  • PN-EN ISO 13299:2010 Sensory analysis—Methodology—General guidelines for determining sensory profiles. Polish Committee for Standardization.

  • PN-ISO 4121:1998 Sensory analysis—Methodology—Evaluation of food products using scaling methods. Polish Committee for Standardization.

  • PN-EN ISO 11036:1999 Sensory analysis. Methodology. Texture profiling. Polish Committee for Standardization

  • Migut, D., Gorzelany, J. & Wołowiec, A. Evaluation of selected chemical properties of fresh and pickled field cucumbers. Inż. Przetw. Spoż. Pol. J. Food Eng. 3, 33–39 (2018).


    Google Scholar
     

  • Kao, C.-C. & Lin, J.-Y. Culture condition optimization of naturally lacto-fermented cucumbers based on changes in detrimental and functional ingredients. Food Chem. X 19, 100839. https://doi.org/10.1016/j.fochx.2023.100839 (2023).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kiczorowski, P., Kiczorowska, B., Samolińska, W., Szmigielski, M. & Winiarska-Mieczan, A. Effect of fermentation of chosen vegetables on the nutrient, mineral, and biocomponent profile in human and animal nutrition. Sci. Rep. 12, 13422. https://doi.org/10.1038/s41598-022-17782-z (2022).

    Article 
    ADS 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zhou, X. et al. Dynamic changes in physic-chemical properties and bacterial community during natural fermentation of tomatoes. Food Sci. Technol. Caminas 42, e63520. https://doi.org/10.1590/fst.63520 (2022).

    Article 

    Google Scholar
     

  • Ghosh, D. Studies on the changes of biochemical, microbiological and sensory parameters of sauerkraut and fermented mix vegetables. Food Res. 5, 78–83. https://doi.org/10.26656/fr.2017.5(1).193 (2021).

    Article 

    Google Scholar
     

  • Singhal, P., Satya, S. & Naik, S. N. Fermented bamboo shoots: a complete nutritional, anti-nutritional and antioxidant profile of the sustainable and functional food to food security. Food Chem. 3, 100041. https://doi.org/10.1016/j.fochms.2021.100041 (2021).

    Article 
    CAS 

    Google Scholar
     

  • Ye, J.-H., Huang, L.-Y., Terefe, N. S. & Augustin, M. A. Fermentation-based biotransformation of glucosinolates, phenolics and sugars in retorted broccoli puree by lactic acid bacteria. Food Chem. 286, 616–623. https://doi.org/10.1016/j.foodchem.2019.02.030 (2019).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Dissanayake, I. H. et al. Lactic acid bacterial fermentation as a biotransformation strategy to enhance the bioavailability of phenolic antioxidants in fruits and vegetables: A comprehensive review. Food Res. Int. 209, 116283. https://doi.org/10.1016/j.foodres.2025.116283 (2025).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Yang, F. et al. Effects of fermentation on bioactivity and the composition of polyphenols contained in polyphenol-rich foods: A review. Foods 12(17), 3315 (2023).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kim, G. Y. et al. Synergistic antioxidant and anti-inflammatory activities of kale juice fermented with Limosilactobacills reuteri EFEL6901 or Limosilactobacills fermentum EFEL6800. Antioxidants 12(10), 1850 (2023).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Yang, X. et al. Antioxidant properties of a vegetable–fruit beverage fermented with two Lactobacillus plantarum strains. Food Sci. Biotech. 27, 1719–1726. https://doi.org/10.1007/s10068-018-0411-4 (2018).

    Article 
    CAS 

    Google Scholar
     

  • Park, S.B., Han, B.K., Oh, H.J., Lee, SJ, Cha, S.K., Park, Y.S., & Choi, H.J. Bioconversion of green tea extract using lactic acid bacteria. Food Eng. Prog. 16, 26–32 (2012).

  • Hu, T., Shi, S. & Ma, Q. Modulation effects of microorganisms on tea in fermentation. Front. Nutr. 9, 931790. https://doi.org/10.3389/fnut.2022.931790 (2022).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Lee, N.-K. & Paik, H.-D. Bioconversion using lactic acid bacteria: ginsenosides, GABA, and phenolic compounds. J. Microbiol. Biotechnol. 27, 869–877. https://doi.org/10.4014/jmb.1612.12005 (2017).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • RuizRodríguez, L. G. et al. Fruits and fruit by-products as sources of bioactive compounds. Benefits and trends of lactic acid fermentation in the development of novel fruit-based functional beverages. Food Res. Int. 140, 109854. https://doi.org/10.1016/j.foodres.2020.109854 (2021).

    Article 
    CAS 

    Google Scholar
     

  • Cvetković, D. et al. Survival of wild strains of Lactobacilli during Kombucha fermentation and their contribution to functional characteristics of beverage. Pol. J. Food Nutr. Sci. 69, 407–415. https://doi.org/10.31883/pjfns/112276 (2019).

    Article 
    CAS 

    Google Scholar
     

  • Nishioka, H., Ohno, T., Iwahashi, H. & Horie, M. Diversity of Lactic acid bacteria involved in the fermentation of Awa-bancha. Microbes Environ. 36, ME21029. https://doi.org/10.1264/jsme2.ME21029 (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Nout, M. J. R. & Ngoddy, P. O. Technological aspects of preparing affordable fermented complementary foods. Food Control 8, 279–287 (1997).

    Article 

    Google Scholar
     

  • Wang, R., Sun, J. C., Lassabliere, B., Yu, B. & Liu, S. Q. Fermentation characteristics of four non-Saccharomyces yeasts in green tea slurry. Food Microbiol. 92, 03609. https://doi.org/10.1016/j.fm.2020.103609 (2020).

    Article 
    CAS 

    Google Scholar
     

  • Wang, R., Sun, J. C., Lassabliere, B., Yu, B. & Liu, S. Q. 13-Glucosidase activity of Cyberlindnera (Williopsis) saturnus var. mrakii NCYC 2251 and its fermentation effect on green tea aroma compounds. LWT 151, 112184. https://doi.org/10.1016/j.lwt.2021.112184 (2021).

    Article 
    CAS 

    Google Scholar
     

  • Martinez-Villaluenga, C. et al. Influence of fermentation conditions on glucosinolates, ascorbigen, and ascorbic acid content in white cabbage (Brassica oleracea var. capitata cv. taler) cultivated in different seasons. J. Food Sci. 74, C62–C67. https://doi.org/10.1111/j.1750-3841.2008.01017.x (2009).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Ciska, E., Honke, J. & Drabińska, N. Changes in glucosinolates and their breakdown products during the fermentation of cabbage and prolonged storage of sauerkraut: focus on sauerkraut juice. Food Chem. 365, 130498. https://doi.org/10.1016/j.foodchem.2021.130498 (2021).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Yang, X. et al. Microbial community dynamics and metabolome changes during spontaneous fermentation of northeast sauerkraut from different households. Front. Microbiol. 11, 1878. https://doi.org/10.3389/fmicb.2020.01878 (2020).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Yang, X. et al. Comparison of northeast sauerkraut fermentation between single lactic acid bacteria strains and traditional fermentation. Food Res. Int. 137, 109553. https://doi.org/10.1016/j.foodres.2020.109553 (2020).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Satora, P., Skotniczny, M., Strnad, S. & Piechowicz, W. Chemical composition and sensory quality of sauerkraut produced from different cabbage varieties. LWT 136, 110325. https://doi.org/10.1016/j.lwt.2020.110325 (2021).

    Article 
    CAS 

    Google Scholar
     

  • Major, N. et al. Bioactive properties, volatile compounds, and sensory profile of sauerkraut are dependent on cultivar choice and storage conditions. Foods 11, 1218. https://doi.org/10.3390/foods11091218 (2022).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Janiszewska-Turak, E., Kołakowska, W., Pobiega, K. & Gramza-Michałowska, A. Influence of drying type of selected fermented vegetables pomace on the natural colorants and concentration of lactic acid bacteria. Appl. Sci. 11, 7864. https://doi.org/10.3390/app11177864 (2021).

    Article 
    CAS 

    Google Scholar
     

  • Yang, H. I. et al. Influence of salt concentration on Kimchi cabbage (Brassica rapa L. ssp. pekinensis) mass transfer kinetics and textural and microstructural properties during osmotic dehydration. J. Food Sci. 88, 1610–1622. https://doi.org/10.1111/1750-3841.16514 (2023).

    Article 
    CAS 
    PubMed 

    Google Scholar
     



  • Source link

    27 11, 2025

    The Natural View SupplySide Global Edition: Problem Solving in the Nutritional Supplement Space

    By |2025-11-27T07:46:06+02:00November 27, 2025|Dietary Supplements News, News|0 Comments


    At SupplySide Global, Philip Bromley, co-founder and CEO of Virun, and Sara Fenn, CEO at O3Omega Smoothies and Virun Marketing Director, talk with Maggie Jaqua of WholeFoods Magazine and Todd Pauli of 24 Stories Marketing about Virun’s mission to bridge the gap between food and supplements, because health shouldn’t taste like punishment.

    Tune in to explore solutions for supplements that taste amazing and work effectively, without toxic additives. Plus, find out what’s on the horizon for 2026

    Bromley and Fenn discuss:

    • The problem of the oxidation of oils, with a look at what happens in that process, and in the case of supplements, how quickly it starts after encapsulation.
    • How oxidation impacts product quality and the consumer experience.
    • How brands can ensure transparency and maintain “clean label” integrity without sacrificing taste.
    • How Virun’s technologies protect omega-3s from oxidation.
    • …and more!

    Content sponsored by Virun.



    Source link

    27 11, 2025

    Analysts See $300 Coming As Remittix Expands Infrastructure With AppStore Release

    By |2025-11-27T07:39:05+02:00November 27, 2025|Crypto News, News|0 Comments

    The Solana price prediction story is heating up again as SOL trades around $135 and begins a fresh recovery wave above the $125 zone. Analysts now say Solana could reach $300 in the next major rally if buyers keep control. At the same time, the Remittix ecosystem has just delivered one of its biggest updates yet. The Remittix Wallet is now live on the Apple App Store, giving early holders real utility while the team prepares a major December upgrade.

    Solana Price Prediction: SOL Tries To Break Key Levels

    Analysts See 0 Coming As Remittix Expands Infrastructure With AppStore Release

    Source: Tradingview

    Solana started a solid recovery above $125 and has reached $128 and then $130. SOL is currently trading above the 100-hour simple moving average, which tends to indicate strength. There is also a bullish trend line that is taking shape around $130. This will provide a price with additional strength in the event the market withdraws.

    The initial significant resistance is at $135, where buyers have been having difficulties. A break of above $145 on clean will open the path to a break of above $155 and perhaps $162. It is the opinion of many analysts that once Solana retains above 130 and breaches the 145 point, a significantly bigger move can come after that.

    Other leading analysts have even moved their long-term price prediction target of Solana to $300, which is backed by a high rate of network activity and a rising market sentiment. SOL may experience some weaknesses despite the bullish set-up in case it fails to breach the limit of $135 in the near future.



    The initial support is at approximately $130, and the price may start to fall to $127 in case of breaking. When SOL falls below $124 by sellers, then further correction to 120 is probable.

    Remittix Expands With App Store Release

    While Solana lines up for a possible run to $300, Remittix (RTX) is gaining attention for a different reason: the team is shipping real products that users can download and use today. The Remittix Wallet is now officially live on the Apple App Store. Remittix has raised more than $28.2 million, and over 686 million RTX tokens have been sold. The current price is $0.1166.

    This is Phase 1, giving users a fast and secure crypto wallet. The next upgrade will bring crypto-to-fiat transfers, letting people send crypto and have the money arrive in bank accounts across 30+ countries. This is the feature many traders believe could turn Remittix into a global PayFi leader.

    Below are reasons why Remittix is getting strong interest:

    • The wallet is live on the Apple App Store, giving the project real-world use right now.
    • Crypto-to-fiat features are coming next, turning the app into a real payments tool.
    • The Remittix Team has passed CertiK Team KYC, adding strong trust and transparency.
    • CEX listings confirmed with BitMart and LBank, and a third exchange already being prepared.
    • A major December announcement is on the way, which could reveal the next stage of the Remittix ecosystem.

    Solana or Remittix: Which One Has More Upside?

    Both assets are gaining attention, but for different reasons. Solana has the momentum of a large network with strong fundamentals, and some analysts believe the long-term Solana price prediction of $300 is realistic if market conditions stay positive.

    Remittix, on the other hand, is focused on real-world payments, expanding infrastructure, and delivering live products during its early growth phase. With the App Store wallet launch and December upgrade coming, many see RTX as a high-upside growth play for 2025.

    FAQs

    1. What is the current Solana price forecast?

    Analysts foresee Solana going to $135, $140, and $145. In case of a break, there are long-term forecasts to indicate $300.

    2. What made analysts believe that Solana would be able to hit 300?

    Good network demand, increased activity, technical recovery, and long-term chart patterns are all signs that there is more room to have a larger rally.

    3. What makes the Remittix App Store launch important?

    It gives Remittix a working product that users can download now, proving the team is delivering real utility early.

    4. When will Remittix add crypto-to-fiat features?

    The team confirmed the upgrade will be added to the same wallet, with a major announcement coming in December.

    5. Is Solana or Remittix better for long-term growth?

    Solana offers strength as a top-10 coin, while Remittix offers early-stage growth potential with real-world payments use cases.

    Discover the future of PayFi with Remittix by checking out their project here:

    Website: https://remittix.io/

    Socials: https://linktr.ee/remittix

    $250K Giveaway: https://gleam.io/competitions/nz84L-250000-remittix-giveaway

    Source link

    27 11, 2025

    Best NMN Supplement Standards: GenuinePurity Establishes Certificate of Authenticity and 96% Purity Verification After FDA Confirms Lawful Status

    By |2025-11-27T05:45:02+02:00November 27, 2025|Dietary Supplements News, News|0 Comments


    Leading Edge Health’s GenuinePurity brand addresses authentication challenges and bioavailability concerns with certificate of authenticity protocols, third-party laboratory verification, and liposomal encapsulation technology following FDA decision confirming NMN lawful status

    LAS VEGAS, Nov. 26, 2025 (GLOBE NEWSWIRE) — FOR IMMEDIATE RELEASE

    Following the FDA’s September 2025 decision confirming that nicotinamide mononucleotide (NMN) is lawful for use in dietary supplements, GenuinePurity announces comprehensive quality verification protocols designed to address persistent consumer confusion in NMN supplement selection. The company’s GenuinePurity Liposomal NMN incorporates certificate of authenticity documentation, third-party laboratory testing showing 96% β-Nicotinamide Mononucleotide purity, and liposomal delivery technology in response to industry-wide challenges including product authentication concerns, absorption barriers, and dosing inconsistencies that affect NAD+ supplement effectiveness.

    Leading Edge Health emphasizes that the FDA decision provides important regulatory clarity that NMN is lawful for use in dietary supplements, confirming legal status for the ingredient-not approval of individual products or specific health claims. The company developed its certificate of authenticity program and third-party purity testing to address authentication concerns affecting consumers seeking reliable NMN supplement options for cellular health support.

    Get the latest news


    delivered to your inbox

    Sign up for The Manila Times newsletters

    By signing up with an email address, I acknowledge that I have read and agree to the Terms of Service and Privacy Policy.

    The FDA’s decision addresses NMN’s classification under dietary supplement regulations but does not constitute endorsement of specific manufacturers, formulations, or marketing claims. Individual product quality depends on manufacturer standards and independent verification.

    Official Website:www.genuinepurity.com

    Important Disclosure: These statements about NMN supplement benefits have not been evaluated by the Food and Drug Administration. GenuinePurity Liposomal NMN is a dietary supplement designed to support healthy NAD+ levels-it is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before beginning any supplement regimen, especially if you have existing medical conditions or take medications. This article contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you.

    TLDR: What You Need to Know About NMN Supplement Quality Standards and FDA Clarification

    The FDA’s September 2025 decision confirming NMN is lawful for use in dietary supplements resolves an important regulatory question while highlighting the need for quality verification standards in a market affected by authentication challenges and bioavailability concerns. If you’re seeking NMN supplements for NAD+ support, consider prioritizing certificate of authenticity documentation, third-party purity testing showing 96% minimum nicotinamide mononucleotide content (the standard GenuinePurity uses), and liposomal encapsulation technology for absorption enhancement. Other NMN supplements may use different purity levels or dosing approaches. GenuinePurity Liposomal NMN by Leading Edge Health combines these quality markers with clinical dose formulation (250mg per serving) and cGMP manufacturing standards developed over 20 years in the natural anti-aging supplement sector. This isn’t about us claiming we’re the best-it’s about giving you the information to make that decision for yourself.

    In This Release, You’ll Discover:

    • How the FDA’s September 2025 decision confirming NMN is lawful for use in dietary supplements affects consumer confidence and quality verification needs in the NMN supplement market
    • Why certificate of authenticity and third-party laboratory testing matter for identifying authentic NMN supplement products when counterfeits exist
    • The three persistent quality challenges you face when selecting NMN supplements: authentication concerns, absorption barriers, and dosing confusion
    • What 96% purity verification means for nicotinamide mononucleotide effectiveness and why GenuinePurity uses this as their quality standard
    • How liposomal encapsulation technology addresses stomach acid degradation that limits regular NMN supplement absorption in your digestive system
    • Why 250mg NMN formulations align with clinical research protocols and provide a research-informed starting point for supplementation
    • What distinguishes liposomal NMN supplement protocols from conventional powder or capsule formats for getting nicotinamide mononucleotide to your cells
    • How you can verify authentic NMN supplement products yourself using certificate of authenticity requests and third-party lab result documentation

    The FDA Decision That Brings New Focus to NMN Supplement Quality Standards

    In September 2025, the FDA issued a decision confirming that NMN is lawful for use in dietary supplements, resolving a regulatory question that had created uncertainty in the NAD+ precursor market. This decision addresses NMN’s legal classification under dietary supplement regulations-it does not constitute approval of individual products, specific formulations, or health claims associated with nicotinamide mononucleotide supplementation.

    The clarification comes as the longevity supplement market experiences significant growth, with consumers increasingly seeking NMN supplement options for cellular health support and NAD+ optimization.

    Here’s what this means for you: regulatory clarity doesn’t automatically resolve the quality verification challenges affecting your supplement selection. Authentication concerns, purity discrepancies, and bioavailability barriers continue to create confusion when you’re trying to identify authentic nicotinamide mononucleotide supplements you can trust.

    Leading Edge Health, a natural anti-aging supplement company with over 20 years of formulation expertise, developed GenuinePurity Liposomal NMN specifically to address these quality gaps through certificate of authenticity protocols, third-party laboratory verification, and liposomal delivery technology.

    The company observes that while the FDA’s decision provides regulatory certainty for NMN’s category status, consumers still face significant challenges identifying authentic products with verified purity and effective delivery systems. Quality standards matter more than ever as market growth attracts both legitimate manufacturers committed to excellence and opportunistic sellers offering substandard formulations.

    The distinction between high-quality NMN supplement options and lower-quality alternatives increasingly depends on verification systems you can independently confirm before making your purchase decision.

    Three Persistent Quality Challenges Affecting Your NMN Supplement Selection

    Consumer reports and industry analysis identify three ongoing problems affecting NMN supplement quality and effectiveness. Let’s break down each challenge and what you can do about it:

    Quality Challenge #1: Product Authentication and Mislabeling Concerns

    The rapid growth of the NAD+ supplement market has created space for sellers offering products with unverified nicotinamide mononucleotide content. Some formulations contain little to no actual NMN despite label claims. Others use lower-purity compounds that don’t meet the 96% nicotinamide mononucleotide standards that research protocols typically specify.

    Industry observers note that authentication concerns in NMN supplement products represent an ongoing issue in the longevity supplement category, with consumers often unable to distinguish authentic formulations from questionable alternatives without independent testing. Previous coverage examining NMN brand quality emphasized the importance of third-party verification in addressing these authentication challenges.

    Your Solution: Certificate of Authenticity Documentation

    Before purchasing any NMN supplement, you should request certificate of authenticity verification. This documentation confirms actual nicotinamide mononucleotide content through independent laboratory analysis-giving you objective proof of what’s actually in the bottle.

    GenuinePurity Liposomal NMN provides certificate of authenticity access to verify 96% β-Nicotinamide Mononucleotide purity through third-party laboratory testing. This isn’t just our claim-it’s independently verified data you can review yourself.

    Quality Challenge #2: Absorption Barriers and Bioavailability Issues

    Research indicates that conventional NMN supplement formulations face degradation from stomach acid exposure, limiting how much actually reaches your cells. Many people report minimal effects from standard powder or capsule formats due to bioavailability challenges that reduce the amount of intact nicotinamide mononucleotide reaching systemic circulation.

    Studies on oral supplement absorption demonstrate that gastric acid pH levels can degrade certain compounds before they reach intestinal absorption sites where your body can use them. This bioavailability barrier affects multiple supplement categories, including NMN products that lack protective delivery systems. Analysis of NMN delivery methods has highlighted how advanced encapsulation technology addresses these absorption limitations.

    Your Solution: Liposomal Encapsulation Technology

    Liposomal delivery systems use phospholipid barriers to protect nicotinamide mononucleotide from gastric acid degradation in your stomach. This technology aims to enhance bioavailability by facilitating direct cellular uptake. Studies on liposomal nutrient delivery show significantly improved absorption compared to non-encapsulated formats.

    Quality liposomal NMN supplements incorporate this technology to help maximize nicotinamide mononucleotide delivery to your cells where NAD+ synthesis actually occurs. GenuinePurity Liposomal NMN uses pharmaceutical-grade phospholipids to encapsulate 96% pure β-Nicotinamide Mononucleotide for enhanced bioavailability-designed to help more of what you take actually reach your cells.

    Quality Challenge #3: Dosing Confusion and Inconsistent Formulations

    The market offers NMN supplement products ranging from 50mg to 1000mg per serving with inconsistent guidance on optimal dosing for you. Many formulations lack connection to clinical research protocols, leaving you uncertain about appropriate nicotinamide mononucleotide intake for NAD+ support.

    Published human studies have examined various NMN dosing protocols, though optimal amounts for different individuals continue to be researched. The inconsistency in marketplace formulations makes it difficult for you to compare products or align your supplementation with emerging research findings.

    Your Solution: Research-Informed Dose Formulation

    Research on human NMN supplementation has examined doses including 250mg daily protocols. GenuinePurity Liposomal NMN incorporates this clinically studied dose combined with liposomal enhancement for improved bioavailability, providing you a research-informed starting point for NMN supplement use.

    Important note about individual NMN supplement needs: Your optimal dose may vary based on age, health status, baseline NAD+ levels, and other factors. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before beginning any NMN supplementation regimen to determine what’s appropriate for your individual situation.

    Why Certificate of Authenticity and Third-Party Testing Define Quality NMN Supplement Standards

    The FDA decision confirming NMN is lawful for use in dietary supplements creates opportunity for quality standardization in the NAD+ supplement market. However, regulatory approval for the ingredient category doesn’t guarantee individual product quality or purity verification for what you’re actually buying.

    If you’re seeking high-quality NMN supplements, here are the quality indicators many practitioners and informed consumers prioritize. Independent reviews examining clean-label formulations have emphasized these same verification standards as critical consumer protection measures.

    Certificate of Authenticity Verification

    This documentation confirms actual nicotinamide mononucleotide content through independent laboratory analysis. Authentic certificates you should look for include:

    • Specific batch testing results showing NMN supplement purity percentage
    • Independent laboratory identification and accreditation details
    • Testing methodology specifics (HPLC or equivalent analytical methods)
    • Date of analysis and batch correlation numbers for traceability
    • Verification that results match label claims for NMN supplement content

    Certificate of authenticity documentation allows you to verify that your NMN supplement choice contains actual nicotinamide mononucleotide at stated purity levels rather than relying solely on manufacturer claims you can’t independently confirm.

    Third-Party Laboratory Testing

    Independent testing removes potential bias from manufacturer self-reporting. Third-party analysis verifies:

    • Actual nicotinamide mononucleotide content versus what the label claims
    • Purity levels (96% β-Nicotinamide Mononucleotide is GenuinePurity’s standard, informed by research protocols)
    • Absence of contaminants or adulterants that could compromise your safety
    • Stability and potency throughout shelf life so you know it works when you use it
    • Verification of other ingredients and delivery system components

    Third-party testing provides objective data you can review when evaluating NMN supplement options, removing your dependence on manufacturer representations alone.

    cGMP Manufacturing Certification

    Current Good Manufacturing Practice (cGMP) standards ensure consistent production quality through:

    • FDA-registered facility operations with regular inspections for your safety
    • Quality control protocols at every production stage
    • Batch testing and documentation for complete traceability
    • Contamination prevention systems and sanitation protocols
    • Raw material verification before manufacturing begins

    GenuinePurity Liposomal NMN incorporates all three quality verification systems to address your concerns about authentic nicotinamide mononucleotide products. The formulation includes 250mg of 96% pure β-Nicotinamide Mononucleotide per serving-this 96% purity standard represents GenuinePurity’s internal quality commitment informed by research protocols, not a regulatory minimum for NMN supplements. You can access certificate of authenticity documentation and third-party laboratory verification conducted by independent testing facilities.

    Understanding Liposomal Delivery: Why Technology Matters for NMN Absorption

    The delivery system significantly affects how much nicotinamide mononucleotide actually reaches your cells. Research on nutrient absorption demonstrates that stomach acid exposure degrades many compounds before they reach intestinal absorption sites where your body can use them.

    The Absorption Challenge with Conventional NMN Supplements

    Standard NMN supplement powder or capsule formats face several bioavailability barriers in your digestive system:

    • Gastric acid degradation reducing intact NMN reaching your small intestine
    • First-pass metabolism limiting systemic circulation after absorption
    • Rapid excretion reducing cellular uptake timeframes
    • Competition with other nutrients for absorption transporters
    • Variable absorption based on your stomach contents and digestive timing

    These factors explain why some people report minimal effects from conventional NMN supplement products despite using verified pure nicotinamide mononucleotide. If the compound degrades before reaching your cells, even high-purity formulations may provide limited NAD+ support for you.

    How Liposomal Encapsulation Aims to Enhance Bioavailability in Your System

    Liposomal technology uses phospholipid spheres (liposomes) to encapsulate nicotinamide mononucleotide molecules. These lipid barriers are designed to provide several absorption advantages for you:

    • Protection from gastric acid degradation to help preserve NMN supplement integrity through your stomach
    • Facilitated cellular uptake through membrane fusion mechanisms
    • Extended circulation time allowing prolonged cellular exposure to nicotinamide mononucleotide
    • Direct intracellular delivery designed to bypass some conventional absorption barriers
    • Reduced degradation from digestive enzymes that affect non-encapsulated formats

    Research on liposomal nutrient delivery, including published studies on vitamin C and glutathione liposomal formulations, demonstrates significantly improved absorption compared to non-encapsulated formats. A recent four-week human trial in healthy adults comparing 350mg liposomal NMN to standard NMN and placebo showed higher NAD+ responses in participants receiving the liposomal format, supporting the general concept of improved delivery, though this represents early-stage evidence from a small study requiring additional confirmation in larger populations.

    Quality liposomal NMN supplements combine this delivery technology with verified purity and clinical dosing for comprehensive quality that addresses both authentication and absorption concerns you face. Detailed analysis of clinically-dosed liposomal encapsulation examines how this technology differentiates premium formulations from standard alternatives.

    Important note about NMN supplement absorption: Individual absorption may vary based on your digestive health, concurrent food intake, medication use, and other personal factors. Bioavailability enhancement technology aims to improve delivery but doesn’t guarantee specific health outcomes for you. Liposomal technology represents an advanced delivery method, not a medical treatment.

    NAD+ Decline and Cellular Health: What Research Shows About Aging and Nicotinamide Mononucleotide

    Understanding why people seek NMN supplements requires context on nicotinamide adenine dinucleotide (NAD+) and its role in your cellular function.

    NAD+ and Your Cellular Energy Production

    NAD+ functions as a coenzyme in hundreds of metabolic reactions in your body, particularly those involving mitochondrial energy production and cellular maintenance processes. Research published in peer-reviewed journals, including studies in Cell Metabolism, Nature Reviews Molecular Cell Biology, and the Journal of Advanced Research, indicates that NAD+ levels decline with age-decreasing approximately 50% between youth and middle age according to some measurements.

    This decline correlates with various age-related changes in cellular function, though establishing direct causation between NAD+ reduction and specific aging processes remains an active area of research with ongoing studies examining the relationship.

    NMN as an NAD+ Precursor in Your Body

    Nicotinamide mononucleotide serves as a direct precursor in the NAD+ biosynthesis pathway in your cells. When your cells absorb NMN supplement compounds, enzymatic processes convert the molecule to NAD+ through established biochemical pathways involving the enzyme NMNAT (nicotinamide mononucleotide adenylyltransferase).

    Research in model organisms, including studies published in Cell, Science, and Nature Communications, demonstrates that NMN supplementation can increase NAD+ levels in various tissues. Human clinical trials examining NMN supplement use have shown measurable increases in blood NAD+ concentrations following oral administration at various doses, though optimal dosing protocols for different individuals and long-term effects continue to be studied in ongoing research.

    Current Research Landscape on NMN Supplementation

    Published studies examining NMN supplement use have explored various potential applications, though most research remains preliminary with important limitations you should understand:

    • Metabolic function and insulin sensitivity (human trials ongoing with limited sample sizes)
    • Cardiovascular health markers (early-stage research primarily in animal models)
    • Cognitive function and neuroprotection (primarily animal studies with human data emerging)
    • Physical performance and muscle function (limited human data from small trials)
    • Cellular aging markers (theoretical mechanisms with ongoing validation)
    • Sleep quality and energy levels (anecdotal reports with minimal controlled research)

    Critical information about NMN supplement research you need to know: Most NMN supplement research uses animal models or small human trials with short duration. Long-term safety and efficacy in diverse human populations like yours requires additional study. Individual responses vary significantly based on your unique biology. NAD+ optimization represents an emerging field with significant unknowns. These statements about NMN supplement benefits and NAD+ support have not been evaluated by the Food and Drug Administration. NMN supplements are dietary supplements designed to support healthy NAD+ levels-they’re not intended to diagnose, treat, cure, or prevent any disease.

    If you’re interested in NAD+ support through NMN supplementation, review current research critically, maintain realistic expectations about what NMN supplementation can and cannot do for you, and consult your healthcare provider regarding whether it’s appropriate for your individual health status and goals.

    How to Identify Authentic NMN Supplement Products: Your Verification Checklist

    The FDA decision confirming NMN is lawful for use in dietary supplements doesn’t automatically ensure product quality across all manufacturers. You can use this verification checklist when evaluating NMN supplement options for yourself. Industry rankings examining NMN brand quality standards have identified these same factors as critical differentiation points among premium and standard formulations.

    Factors Many Informed Consumers Consider Before Purchase:

    • Request certificate of authenticity showing 96% minimum β-Nicotinamide Mononucleotide purity from independent testing
    • Verify third-party laboratory testing from independent accredited facilities (not just manufacturer testing you can’t independently confirm)
    • Confirm cGMP certification for manufacturing facilities (FDA-registered preferred for quality assurance)
    • Review company history and longevity in supplement manufacturing (established companies often have better quality systems in place)
    • Examine delivery system technology (liposomal encapsulation aims to enhance bioavailability versus standard formats for getting NMN to your cells)
    • Compare dosing to clinical research protocols (250mg represents a studied dose in human trials you can reference)
    • Verify country of manufacture and regulatory compliance standards
    • Check for transparency in ingredient sourcing and testing methodologies
    • Confirm availability of customer service for quality verification questions you may have
    • Review return policies and satisfaction guarantees (quality companies stand behind their products)

    Red Flags You Should Avoid:

    • Inability or unwillingness to provide certificate of authenticity upon your request
    • Absence of third-party laboratory verification or only manufacturer self-testing
    • Vague or incomplete ingredient disclosure on labels
    • Unrealistic health claims or cure promises for diseases
    • Significantly below-market pricing suggesting quality compromises or counterfeit risk
    • New companies without manufacturing history or quality track records
    • Lack of professional customer service or educational resources to answer your questions
    • No clear information on purity percentages or testing methods
    • Unclear dosing instructions or formulation details

    GenuinePurity Liposomal NMN by Leading Edge Health addresses these evaluation factors through certificate of authenticity provision you can access, third-party laboratory testing you can review, cGMP manufacturing certification, and 20+ years of company history in natural anti-aging formulations with established quality systems. These represent GenuinePurity’s quality standards informed by research and industry best practices, not regulatory minimums that all NMN supplements must meet.

    Current NAD+ Supplement Market: Growth, Challenges, and Quality Evolution

    The longevity supplement market has experienced significant expansion as consumer interest in healthy aging accelerates. Market analysis indicates substantial growth in NAD+ precursor products, including NMN supplement and nicotinamide riboside (NR) formulations, with projections suggesting continued expansion through 2026 and beyond as people like you seek cellular health support options.

    Market Growth Factors Affecting Your Options:

    • Increased public awareness of NAD+ research findings from major universities
    • Aging population demographics seeking preventive health strategies
    • Interest in cellular health optimization and longevity science
    • Accessibility of direct-to-consumer supplement purchasing online
    • Media coverage of aging research and NAD+ studies
    • Growing wellness industry emphasis on cellular health approaches

    Persistent Market Challenges You Face:

    • Quality inconsistency across manufacturers in the NMN supplement category
    • Ongoing reports of mislabeling and unverified NMN supplement content in the marketplace
    • Consumer confusion about effective dosing and delivery methods for your needs
    • Variable pricing with unclear value differentiation between products
    • Incomplete consumer education on quality verification methods you can use
    • Mixing of legitimate research with exaggerated marketing claims
    • Lack of standardized industry testing protocols you can rely on

    The recent FDA decision provides regulatory foundation for market maturation, but quality standardization requires manufacturer commitment and consumer education on verification methods you can employ to protect yourself.

    Industry observers note that companies with established quality systems, like Leading Edge Health’s 20+ year track record in natural anti-aging supplements, may be better positioned to meet emerging quality standards as the NMN supplement market evolves toward greater consumer protection and authentication requirements that benefit you.

    GenuinePurity Liposomal NMN: Quality Response to Market Verification Needs

    Leading Edge Health developed GenuinePurity Liposomal NMN specifically to address the quality gaps affecting NMN supplement selection in response to persistent consumer confusion and authentication concerns reported in the marketplace.

    Quality Verification Systems You Can Access:

    • Certificate of Authenticity: Available for your verification of 96% β-Nicotinamide Mononucleotide purity through third-party laboratory analysis of each production batch
    • Third-Party Testing: Independent laboratory verification confirms NMN supplement content and purity specifications using HPLC methodology you can review
    • Liposomal Technology: Pharmaceutical-grade phospholipid encapsulation designed to enhance bioavailability by protecting NMN from gastric acid degradation in your digestive system
    • Clinical Dose: 250mg nicotinamide mononucleotide per serving aligns with human research protocols examined in published studies
    • cGMP Manufacturing: FDA-registered facilities with current Good Manufacturing Practice certification
    • Quality Assurance: Batch testing and stability verification throughout shelf life to help maintain potency when you use it

    Manufacturing Standards for Your Safety:

    The formulation is produced in the United States using cGMP-certified facilities with FDA registration. Manufacturing protocols include:

    • Raw material verification before production begins to confirm ingredient identity and purity
    • In-process quality controls during manufacturing to ensure consistency
    • Final product testing for potency and purity before release to you
    • Stability testing to ensure shelf-life integrity under various conditions
    • Contamination prevention systems and sanitation protocols
    • Batch documentation and traceability systems

    Formulation Specifications:

    Each serving of GenuinePurity Liposomal NMN contains:

    • 250mg β-Nicotinamide Mononucleotide (96% purity minimum verified by third-party testing-this represents GenuinePurity’s quality standard)
    • Liposomal encapsulation using pharmaceutical-grade phospholipids designed to enhance absorption in your system
    • No genetically modified organisms (Non-GMO verified)
    • Free from gluten, soy, dairy, eggs, and common allergens that might affect you
    • No artificial preservatives or synthetic fillers
    • Organic ingredients where applicable in formulation
    • No sugar, wheat grain, or unnecessary additives

    Important note about NMN supplement results: Individual results may vary significantly based on your age, health status, baseline NAD+ levels, lifestyle factors, and other personal variables. Product specifications current as of January 2026 and subject to formulation updates. These statements about NMN supplement benefits and NAD+ support have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. GenuinePurity Liposomal NMN is a dietary supplement designed to support healthy NAD+ levels in your body.

    Company Background: Leading Edge Health’s 20+ Years in Natural Anti-Aging Formulations

    Leading Edge Health has specialized in natural anti-aging supplement development for over two decades, establishing quality protocols that inform current GenuinePurity product lines including NMN supplement offerings available to consumers seeking verified quality.

    Company History: Founded in the early 2000s, Leading Edge Health focused on science-based formulations addressing age-related health concerns through natural compounds and advanced delivery technologies.

    The company pioneered several approaches now common in the longevity supplement industry, including:

    • Third-party laboratory testing protocols before widespread industry adoption
    • Certificate of authenticity systems for ingredient verification you can access
    • Advanced delivery technologies including liposomal encapsulation for enhanced bioavailability
    • Clinical dose formulations based on published research rather than arbitrary amounts
    • Comprehensive quality control throughout manufacturing processes
    • Consumer education resources alongside product availability to help you make informed decisions

    Manufacturing Philosophy:

    The company’s approach emphasizes:

    • Quality verification over cost reduction in sourcing and production
    • Transparency in ingredient sourcing and testing methodologies you can review
    • Science-informed formulation development based on peer-reviewed research
    • Consumer education alongside product availability to support your informed decisions
    • Long-term safety considerations in all formulations rather than short-term trends
    • Partnership with FDA-registered, cGMP-certified manufacturing facilities

    Current Product Lines: The GenuinePurity brand represents Leading Edge Health’s premium quality tier, incorporating the highest manufacturing and verification standards developed over the company’s operational history. GenuinePurity Liposomal NMN extends these quality commitments to the NAD+ precursor category in response to market needs for authenticated NMN supplement options you can trust.

    Accessing Verified NMN Supplement Products: Your Consumer Resources and Information

    If you’re seeking authentic GenuinePurity Liposomal NMN with certificate of authenticity and third-party testing verification you can review, you’ll find product information through the official GenuinePurity website, which provides educational resources on NAD+ optimization, quality verification systems, and current product specifications.

    The website includes resources for you:

    • Detailed formulation information and complete ingredient disclosure
    • Certificate of authenticity request procedures for batch verification
    • Third-party laboratory testing result access for your transparency
    • Educational content on NMN supplement quality standards and selection criteria
    • Customer service contact for product verification questions and technical information you may need
    • Current shipping and handling information for domestic and international orders
    • Research references and published studies on NAD+ and NMN you can review

    Leading Edge Health maintains customer service operations to address your product questions, quality verification requests, and supplement education needs. Representatives are available through contact information provided on the official website during business hours to answer your questions.

    Important note about NMN supplement product information: Product availability, specifications, and pricing are subject to change without notice. You should verify current information through official sources before purchase. International customers should check local regulations regarding NMN supplement legality and import requirements before ordering. Always confirm current pricing on the official website as pricing is subject to change at any time.

    Important Information You Should Know: Consumer Guidance and Professional Consultation

    What You Need to Know About FDA Evaluation of NMN Supplement Claims:

    These statements about NMN supplement benefits and NAD+ support have not been evaluated by the Food and Drug Administration. GenuinePurity Liposomal NMN is a dietary supplement designed to support healthy NAD+ levels in your body-it’s not intended to diagnose, treat, cure, or prevent any disease. The FDA’s September 2025 decision confirms NMN’s lawful status in the dietary supplement category, which addresses an important legal classification question. However, this decision does not constitute FDA approval of individual NMN supplement products, specific manufacturers, or health claims associated with nicotinamide mononucleotide supplementation. Your product quality depends on manufacturer standards and independent verification, not FDA endorsement.

    When You Should Consult Your Healthcare Provider About NMN Supplementation:

    You should consult qualified healthcare providers before beginning any new supplement regimen, especially if you:

    • Have existing medical conditions or chronic health concerns requiring ongoing treatment
    • Take prescription medications that may interact with supplements (particularly those affecting NAD+ metabolism or methylation pathways)
    • Are pregnant, nursing, or planning pregnancy (safety data limited in these populations)
    • Have known allergies or sensitivities to supplement ingredients or phospholipids
    • Are under 18 years of age (research primarily conducted in adult populations)
    • Are scheduled for medical procedures or surgeries (discuss supplement timing with your providers)
    • Have autoimmune conditions or compromised immune function
    • Are taking medications for diabetes, blood pressure, or other metabolic conditions

    Your healthcare provider can help you determine if NMN supplementation is appropriate for your individual situation and can monitor your response to supplementation over time.

    Understanding Current Research Limitations on NMN Supplements:

    While emerging research on NMN supplement use shows promise for supporting healthy NAD+ levels, you should understand that long-term safety and efficacy data in diverse human populations remains limited. Most published studies use animal models or small-scale human trials with short duration. You should maintain realistic expectations and view NAD+ support as one component of comprehensive health strategies that include quality nutrition, regular exercise, stress management, adequate sleep, and regular medical care tailored to your needs.

    NMN supplements often produce different results in different individuals based on your unique biology, lifestyle, and health status. Research continues to explore optimal dosing, timing, and individual factors that may influence NMN supplementation outcomes for people like you.

    Information About NMN Supplement Pricing and Availability:

    Product pricing, package options, and availability are subject to change without notice based on manufacturing costs, ingredient availability, and market conditions. You should verify current pricing, shipping costs, promotional offers, and product specifications through official sources before making your purchase decision. Information in this release reflects conditions as of January 2026. Prices mentioned in any context should always be confirmed on the official website as pricing is subject to change at any time based on factors outside manufacturer control.

    What to Expect: Individual Results Variation with NMN Supplementation:

    Supplement effects vary significantly based on your individual factors including age, baseline NAD+ levels, health status, genetics, diet quality, lifestyle factors, concurrent medications, stress levels, sleep quality, and numerous other variables unique to you. No supplement-including high-quality NMN products-guarantees specific outcomes for all users. Your experience with NMN supplementation may differ from others based on your unique biochemistry and circumstances.

    Some people report noticing effects within weeks of starting NMN supplementation, while others may require longer periods or may not experience subjectively noticeable changes despite measurable increases in NAD+ levels. Your response is individual to you.

    About Leading Edge Health

    Leading Edge Health is a natural anti-aging supplement company with over 20 years of formulation expertise in science-based longevity products. The company operates through Canadian and international offices, maintaining cGMP-certified manufacturing partnerships in FDA-registered facilities located in the United States. The GenuinePurity product line represents the company’s premium quality tier, incorporating certificate of authenticity protocols, third-party laboratory testing, and advanced delivery technologies including liposomal encapsulation systems. GenuinePurity Liposomal NMN addresses quality verification needs in the NMN supplement market through 96% purity verification (the company’s internal quality standard), clinical dose formulation, and enhanced bioavailability technology designed to support your NAD+ optimization goals.

    Contact Information: Leading Edge Health Inc. 300-1095 McKenzie Avenue Victoria, BC V8P 2L5 Canada

    Customer Service: 1-866-968-6643 (North America, toll-free) International: +1-778-770-2961 Email: [email protected]

    Website:www.genuinepurity.com

    For media inquiries, product information, certificate of authenticity verification requests, or third-party testing documentation, contact the customer service team during business hours (6am-6pm Pacific Time, Monday-Friday, excluding holidays).

    This article contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you.

    END OF RELEASE

    CONTACT: Customer Service: 1-866-968-6643 (North America, toll-free) International: +1-778-770-2961 Email: [email protected]



    Source link

    27 11, 2025

    Bitcoin BTC USD price prediction latest news: Bitcoin price target: JPMorgan predicts BTC USD could hit $240,000 and reveals why crypto is acting like a macro asset

    By |2025-11-27T05:38:14+02:00November 27, 2025|Crypto News, News|0 Comments

    Bitcoin price prediction: Bitcoin could rise to $240,000 over the long term, according to a recent JPMorgan note that examines how the asset’s market structure is changing. The projection arrives during a weak stretch for the crypto market, with BTC USD having fallen sharply from its early October peak of $126,000 to around $82,000 in November.

    JPMorgan: Crypto Markets Now Driven by Macro Trends, Not the Halving Cycle

    In its latest note, JPMorgan said crypto markets are increasingly driven by macroeconomic trends rather than Bitcoin’s familiar halving cycle, which historically preceded major bull runs, as per a report.

    The bank said that, “Crypto is moving away from resembling a venture capital style ecosystem to a typical tradable macro asset class supported by institutional liquidity rather than retail speculation,” as quoted by The Street.

    Institutional Investors Replace Retail Traders in Crypto Markets

    The analysts wrote that, “Cryptocurrency prices are now more influenced by broader economic trends rather than crypto’s predictable four-year halving cycle, the process where the rate of new supply of Bitcoin is cut in half and followed by a bull market rally,” as quoted in the report.

    The bank explained that retail participation has dropped and institutional investors now provide market depth, which stabilises flows and potentially anchoring long-term prices.


    ALSO READ: AI is taking over Thanksgiving & Black Friday shopping: How to get tech deals even as tariffs drive prices up

    BTC USD Target: Bitcoin Price Could Reach $240,000

    At a JPMorgan event, one speaker suggested that Bitcoin could potentially reach $240,000 over the long term, describing BTC not as a cyclical asset but as a multi-year growth opportunity, as per The Street report.Despite the structural shift, JPMorgan cautioned that crypto remains a “liquid yet structurally inefficient” market. Because liquidity is uneven, the asset class can still experience sudden and severe price swings.

    JPMorgan Introduces New Structured Note Linked to BlackRock’s IBIT

    The bank also filed a new structured product tied to BlackRock’s iShares Bitcoin Trust ETF (IBIT). The note offers the possibility of uncapped upside through 2028 if Bitcoin rallies, but with several conditions, as per The Street.

    ALSO READ: Thanksgiving 2025: Full list of fast food & restaurants open and closed – McDonald’s, Starbucks, Cracker Barrel, Subway, Krispy Kreme and more

    How JPMorgan’s Bitcoin-Linked IBIT Note Works for Investors

    If IBIT reaches or exceeds JPMorgan’s preset price by the end of 2026, the bank redeems the note early and pays investors a minimum return of 16 percent.

    If IBIT stays below that level, the note continues through 2028 with leveraged exposure. Investors may earn 1.5 times their principal with no upper limit if IBIT surpasses the bank’s 2028 target.

    The structure includes downside protection, allowing investors to recover principal in 2028 unless IBIT drops more than 30 percent that year.

    However, the bank’s risk disclosure warns that the product does not guarantee the return of principal. If the note is not called early and IBIT’s final value ends below the barrier, investors will lose 1 percent of their principal for every 1 percent decline in the ETF. Under some outcomes, investors could lose their entire principal.

    FAQs

    What price does JPMorgan think Bitcoin price BTC USD could reach long term?

    JPMorgan says Bitcoin could potentially climb to $240,000 over the long term.

    Is the halving cycle still influencing Bitcoin?

    JPMorgan says broader economic trends now play a bigger role than the halving cycle.

    Source link

    27 11, 2025

    Gold Price Forecast – XAU/USD Targets $5,500 as Dollar Weakness Boost Bullish Momentum

    By |2025-11-27T04:16:01+02:00November 27, 2025|Forex News, News|0 Comments


    Gold (XAU/USD) Holds Above $4,150 as Global Rate Cuts, Central Bank Demand, and ETF Flows Drive Renewed Bullish Momentum

    Gold (XAU/USD) trades at $4,167 per ounce, regaining strength after weeks of consolidation and touching a two-week high of $4,169. The move reflects a decisive rotation into safe-haven assets as weak U.S. data fuels expectations of a December Federal Reserve rate cut, now priced at over 80% probability, up sharply from 50% last week. The metal has now gained 57.9% year-to-date, supported by persistent central bank accumulation, ETF inflows, and the broad weakening of the U.S. dollar. Gold’s current trading range between $3,900 and $4,400 forms the tightest and most critical consolidation zone of 2025, and the upcoming Fed meeting on December 17–18 is likely to determine whether the next leg is toward $4,500 or back to $4,000 support.

    Federal Reserve Dovish Shift Triggers Rally in XAU/USD

    The U.S. macro backdrop remains the defining driver. Retail sales missed forecasts, consumer confidence fell to 88.7 — the lowest since May, and PPI data stagnated. These weak readings have accelerated expectations for monetary easing. Treasury yields dropped for a fourth straight session, with the 10-year yield sliding below 4.02%, reinforcing the narrative of a softer dollar environment. Fed officials, including Christopher Waller, have signaled openness to rate cuts in response to slower inflation and labor softening. The result has been a notable reduction in real yields — a major tailwind for non-yielding assets such as gold. XAU/USD benefits directly: the lower yield environment reduces opportunity cost, and dovish expectations now imply a two-cut cycle in H1 2026, which could sustain the gold uptrend into the mid-$4,000s.

    Technical Structure: Gold Builds a Strong Base Above $4,000

    Technically, XAU/USD shows sustained momentum. Immediate resistance sits at $4,210, followed by secondary resistance at $4,370–$4,400, corresponding to historical highs. Support levels hold firm at $4,150, $4,000, and $3,900, with a wider safety buffer between $3,300 and $3,450 aligning with the 200-day EMA. The Relative Strength Index (RSI) on the 4-hour chart remains above 60, signaling ongoing bullish momentum, while the MACD histogram shows a widening green spread, confirming positive price acceleration. The 50-day EMA near $4,000 acts as a key psychological and structural defense zone. If gold breaches $4,210, the path opens toward $4,370, and ultimately the Fibonacci extension targets at $5,000 (100%) and $5,500 (161.8%) projected from the July-to-October impulse wave.

    Institutional Forecasts Reinforce Long-Term Upside in XAU/USD

    Institutional projections now converge on a higher 2026 target range: Deutsche Bank raised its forecast to $4,450/oz, expecting a $3,950–$4,950 trading range next year, with persistent ETF inflows maintaining a strong support floor near $3,900. Goldman Sachs predicts a $4,900 target by late 2026, citing 75 bps in expected global rate cuts and renewed central bank diversification after the freezing of Russian reserves. Bank of America foresees a $5,000 level, driven by U.S. deficit expansion and inflationary fiscal policy under Trump’s administration. HSBC projects a $3,600–$4,400 range, acknowledging geopolitical risk and global trade tensions as persistent supports but noting potential drag from higher physical supply and slowed bank purchases. Despite differing targets, the institutional alignment on the $4,400–$5,000 band underlines a unified bullish bias rooted in both policy and structural drivers.

    Central Bank and ETF Demand Create Structural Floor for Gold

    Deutsche Bank analyst Michael Hsueh highlighted that gold’s performance is being underpinned by inelastic official-sector demand. Central banks continue to accumulate aggressively, seeking protection against geopolitical and reserve risks. Surveys show the highest percentage of central banks planning gold accumulation in years, with one respondent calling gold the “ultimate protection against black-swan tail risk events.” Official purchases in Q3 ranked as the third-highest on record, even at elevated price levels. ETF flows have also reversed four years of outflows, shifting back to net accumulation. This institutional behavior absorbs supply that would otherwise enter the jewelry and industrial markets, creating an artificial scarcity that supports price floors. Physical supply growth remains constrained: 2026 mined output is expected at 3,715 tonnes, with disruptions at Indonesia’s Grasberg mine offsetting new projects. Recycling rates remain below historical peaks, and major miners still model internal assumptions at $2,500–$3,000, limiting capacity expansion. This structural mismatch — expanding official demand versus inelastic supply — continues to define the bullish setup for XAU/USD into 2026.

    Market Psychology: Investors Underexposed to Gold Despite Record Run

    According to a Bank of America fund manager survey, only 5% of global portfolio managers expect gold above $5,000 by 2026, while 39% hold no gold exposure at all. This imbalance between price strength and institutional participation signals latent upside. Historically, similar conditions — strong fundamentals combined with under-allocation — preceded multi-quarter rallies. The Kobeissi Letter data underscores this divergence: 34% of investors expect gold between $4,000 and $4,500, while just 8% predict sub-$3,500 levels. Such skepticism amid structural demand growth suggests gold remains under-owned relative to macro risk, positioning it as one of the few assets capable of outperforming in both inflationary and deflationary environments.

    Macroeconomic and Geopolitical Context Supports XAU/USD

    Persistent geopolitical and fiscal instability continues to reinforce the appeal of gold. The U.S. fiscal deficit is widening sharply, with debt-to-GDP expected to exceed 122% in 2026, sustaining long-term inflationary pressure. Simultaneously, ongoing tariff escalations under the Trump administration raise global trade friction and increase demand for neutral assets like gold. In parallel, China and India — representing over 50% of global retail gold demand — remain key stabilizers. Seasonal physical buying, particularly ahead of the Lunar New Year, tends to amplify price strength in early Q1. The Dollar Index (DXY) remains below 100, its lowest in 12 months, while global liquidity measures continue to improve as central banks loosen policy. Combined, these conditions suggest macro tailwinds remain intact for XAU/USD through the first half of 2026.

    Technical Projection: Fibonacci Structure Points Toward $5,500

    Fibonacci mapping from July lows to October highs sets a 100% extension target at $5,000 and 161.8% extension above $5,500, validating the bullish case. The $4,200–$4,210 resistance remains the immediate test area; breaking it confirms the start of an expansion phase toward the upper bound. Momentum indicators show constructive alignment. The Stochastic Oscillator at 62 and CCI at +84 support continued upward bias. Volumes have begun expanding again on each up-leg, confirming institutional re-entry. A sustained close above $4,210 unlocks the $4,370–$4,400 zone, while closing above $4,400 shifts focus toward $4,900. Conversely, a break below $4,000 risks a pullback to $3,900, though long-term support near $3,300–$3,450 ensures the broader uptrend remains structurally intact.

    Strategic Outlook for Gold (XAU/USD): Institutional Accumulation Meets Retail Skepticism

    The juxtaposition of official sector accumulation, ETF re-engagement, and investor skepticism creates a textbook setup for asymmetric upside. The Deutsche Bank, Goldman Sachs, and BofA alignment near $4,900–$5,000 underscores that even conservative models expect double-digit gains through 2026. The combination of lower real yields, persistent inflation, tight mine supply, and currency debasement risks continues to position gold as the premier macro hedge. Every pullback into the $3,900–$4,000 range remains a high-probability accumulation zone for long-term investors. Verdict: STRONG BUY — Gold (XAU/USD) is fundamentally and technically supported for continued appreciation. The next major breakout above $4,210 opens room toward $4,400, followed by $5,000–$5,500 Fibonacci targets. Downside risk remains limited while real rates and U.S. fiscal policy both point to sustained medium-term bullish momentum.

    That’s TradingNEWS

     





    Source link

    27 11, 2025

    GBP to USD Forecast: Pound Sterling Breaks Above $1.32 After Budget Boost

    By |2025-11-27T03:53:02+02:00November 27, 2025|Forex News, News|0 Comments


    – Written by

    The Pound-to-Dollar exchange rate (GBP/USD) climbed above $1.32 on Wednesday as UK Chancellor Rachel Reeves delivered her autumn budget.

    At the time of writing, GBP/USD was trading around $1.3207, up roughly 0.3% from its opening levels.

    The Pound (GBP) strengthened through Wednesday as Chancellor Rachel Reeves finally unveiled her much-anticipated autumn budget, ending weeks of uncertainty.

    Sterling was boosted by refreshed forecasts from the Office for Budget Responsibility (OBR), which pointed to stronger growth prospects in 2025 than previously expected.

    Investor confidence was also helped by the bond market reaction, with a drop in UK gilt yields signalling broad approval of Reeves’s fiscal package.

    The US Dollar (USD) remained under pressure on Wednesday, with demand for the safe-haven currency fading amid a wave of improved risk appetite.

    A key driver of the upbeat mood was renewed optimism surrounding a potential peace deal between Ukraine and Russia, with reports suggesting encouraging progress in ongoing talks.

    Save on Your GBP/USD Transfer

    Get better rates and lower fees on your next international money transfer.
    Compare TorFX with top UK banks in seconds and see how much you could save.


    Compare the Best GBP/USD Rates »

    Further weighing on the Dollar were increasingly dovish expectations for future Federal Reserve policy.

    Markets continue to price the possibility of a December rate cut, while speculation over Fed leadership added another layer of caution.

    White House Economic Adviser Kevin Hassett is now widely seen as a frontrunner to replace Jerome Powell next year – a potential shift that could tilt the Fed in a more dovish direction.

    GBP/USD Forecast: Post-Budget Analysis to Drive Sterling Volatility

    Looking to Thursday, deeper scrutiny of the autumn budget is likely to influence further movement in the Pound to US Dollar exchange rate.

    Investors will assess how Reeves’s tax and spending plans may shape Bank of England (BoE) monetary policy – particularly whether tighter fiscal settings increase pressure on policymakers to support growth through additional rate cuts.

    Meanwhile, with US markets closed for Thanksgiving, lighter trading conditions could leave the Dollar more vulnerable to shifts in overall risk appetite. If optimism holds, USD may struggle to regain momentum.

    Like this piece? Please share with your friends and colleagues:




    International Money Transfer? Ask our resident FX expert a money transfer question or try John’s new, free, no-obligation personal service! ,where he helps every step of the way,
    ensuring you get the best exchange rates on your currency requirements.

    TAGS: Pound Dollar Forecasts

    Source link

    27 11, 2025

    Annual organic certification a burden for tea farmers

    By |2025-11-27T03:44:11+02:00November 27, 2025|Dietary Supplements News, News|0 Comments


    By Kokila Dhakal,Ilam, Nov. 27: The annual fees required for organic certification—already an expensive and compulsory process—have increasingly become a major burden for Nepali orthodox tea producers. 

    The organic certification process, mandatory for Nepali tea to be exported to third countries, is already complicated and cumbersome. Since Nepal does not have its own organic certification system, tea farmers and industries have been forced to pay large sums of money every year to foreign agencies, tea producers say. 

    Until now, Nepali tea has been certified organic by international organisations such as NASA, SRES and IOM.

    “Our tea is exported mainly to third countries, and certification is absolutely mandatory for that. If we fail to present renewed certificates, foreign buyers raise questions,” said Tanka Dahal, proprietor of Greenhill Tea Industries in Sakhèjung, Ilam. Organic certification costs Rs. 700,000 to 800,000 annually. Organic certificates must also be renewed every year. 

    According to Dahal, for the renewal process, farmers must reapply, after which inspectors from the respective agencies visit tea farms to monitor what is being used on the tea plants. The certificates are renewed only after the inspectors submit reports based on their on-site assessments.

    Sharad Subba, a Jasbire-based tea producer in Ilam who has been producing organic tea for many years, said that organic certification and renewal have become a significant financial burden for both farmers and tea entrepreneurs. 

    Subba, recognised as ‘one of Nepal’s best tea makers’, says that even though many plantations were certified in the past, the requirement for continuous renewal has created difficulties, especially for small farmers.

    As foreign consumers increasingly prefer organic tea, small farmers, cooperatives and industries have been attempting to produce fully organic tea on their own. However, farmers say that sustaining this practice for the minimum required period of three to four years becomes financially challenging. After submitting an application for certification, farmers must themselves bear the cost of continuous monitoring by the certifying agency for three years.

    Nevertheless, for better prices and export opportunities, there is no alternative to organic certification, said Rabin Rai, General Secretary of the Central Tea Cooperative Federation.

    Uttam Kumar Shrestha, former president of the Suryodaya Orthodox Tea Producers Association – the umbrella orgaisation of orthodox tea industries across Nepal, also said that although organic production holds the future of Nepali tea, the absence of an organic certification system within Nepal has created problems.

    “The government spends billions in various sectors, including agriculture, but has done nothing for tea,” Shrestha said. “Even if there is no specific programme for small tea farmers, it would have been immensely helpful if the government had established at least one organic certification laboratory within the country.” 

    According to him, small farmers have been compelled to spend hundreds of thousands of rupees abroad solely for certification. So far, several tea factories and estates—including Shangri-La Tea Factory in Sakhèjung, Gorkha Tea Estate in Sundarpani, Kanchenjungha Tea Estate in Panchthar, Sandakpur Tea Factory in Maipokhari, Jasbire Tea Factory, and the Brothers Tea Industry in Deumai—have obtained organic certification from NASA, IOM and SRES. 

    Likewise, the High-Hill Tea Producers Cooperative in Sakhèjung, Sundarpani Tea Producers Cooperative under Gorkha Tea Estate, Eco Cooperative in Kolbung, and Himshikhar Tea Producers Cooperative under Panchakanya have received organic certification from NASA.

    According to the Central Tea Cooperative Federation, Greenhill in Sakhèjung, Tinjure Cooperative in Chamaita, Ilameli Tea Cooperative in Fikkal, and Ajambare, Deurali and Nawami Tea Producers Cooperatives in Jitpur have been certified organic by the European organic agencies SRES and IOM. Industries and cooperatives also said that farmers producing organic tea receive higher prices for green leaves throughout the year. 

    The price of organic green leaves is up to Rs. 1,600 per kg, depending on quality. From these leaves, various types of teas—such as green tea, golden tea, white tea, oolong tea, golden pearl and golden ring—are produced, which international consumers highly appreciate, said master tea maker Sharad Subba.





    Source link

    27 11, 2025

    Dogecoin (DOGE) Price Prediction: Technical Patterns Suggest Conditional Upside as Market Seeks Direction

    By |2025-11-27T03:37:12+02:00November 27, 2025|Crypto News, News|0 Comments

    Dogecoin’s chart is flashing early stabilization signals as new triangular and channel formations emerge, giving traders fresh technical clues after several weeks of choppy, uncertain price action.

    Recent multi-timeframe analysis on TradingView shows DOGE attempting to regain structure following a prolonged pullback, with price hovering near $0.15 as of November 26, 2025. While still far below its 2021 peak, the latest patterns suggest the market may be forming a potential base as volatility compresses across the 4-hour, daily, and weekly charts.

    Current Price Structure and Short-Term Outlook

    On the 4-hour chart, DOGE is attempting to break above a falling wedge—a pattern that can signal bullish momentum when confirmed by price closes and volume expansion. Using standard technical criteria:

    • The price has moved above the wedge’s upper trendline with two consecutive closes,

    • Volume shows a 12% uptick compared to the previous 4-hour average,

    • RSI has recovered from oversold territory toward a neutral zone.

    Market analyst Alan T., who has covered crypto price structure analysis for over five years, notes an emerging inverse head-and-shoulders formation. He estimates a measured-move target near $0.18, representing an approximate 18% upside if the breakout holds.

    Dogecoin’s repeating fractal structure suggests the potential for a significant upward move, though a $5 target remains highly speculative and dependent on broader market conditions. Source: @Bitcoinsensus via X

    Short-term resistance levels—based on historical price clusters and Fibonacci retracement zones—include:

    These levels act as potential targets, not certainties. A breakdown back inside the wedge would invalidate the immediate bullish bias.

    Historical Patterns and Mid-Term Expectations

    Dogecoin has displayed repeating fractal behaviors across multiple market cycles. When viewed on a log-scaled weekly chart, triangular consolidations followed by channel-based expansions have preceded notable rallies in 2017, early 2021, and late 2023.

    Dogecoin (DOGE) Price Prediction: Technical Patterns Suggest Conditional Upside as Market Seeks Direction

    DOGE is showing strengthening bullish momentum on the 4H chart after a confirmed falling-wedge breakout, with price reclaiming key support and targeting the $0.215 level for a potential 41.5% advance. Source: CryptoWithJames on TradingView

    While some analysts draw parallels between current and past structures, such an interpretation requires caution: fractals highlight similarity, not predictability.

    Platforms such as CoinCodex, which use a blend of volatility models and moving-average trend projections, estimate a potential $0.39–$0.73 range for late 2025 if broader crypto conditions remain favorable.

    Key Price Drivers and Market Factors

    1. Social Media & Influencers: DOGE remains highly reactive to social media commentary—especially from high-profile figures. This creates rapid but often short-lived volatility spikes.

    2. Market Sentiment: The Crypto Fear & Greed Index shows 19 (Extreme Fear). Historically, such readings have sometimes aligned with early accumulation phases, but do not guarantee reversals.

    Key Price Drivers and Market Factors

    Dogecoin has broken out of its 4-hour inverse head-and-shoulders pattern, signaling a potential move toward an estimated 18% upside. Source: @TATrader_Alan via X

    3. Institutional Interest: Reports from industry outlets indicate that asset managers such as Grayscale and 21Shares have explored DOGE-related ETF products. Approval of such vehicles could introduce new liquidity, though none are finalized at the time of writing.

    4. Technical Indicators: DOGE trades below both its 50-day and 200-day moving averages, signaling a broader downtrend. However, low-volume consolidation near support often precedes trend transitions.

    5. Tokenomics: Dogecoin’s uncapped supply, increasing by roughly 5 billion coins annually, limits scarcity. This makes long-term valuation more dependent on demand growth than on supply restriction—unlike Bitcoin’s capped model.

    Analyst Outlook and Risk Considerations

    Short-term momentum remains fragile. Key supports at $0.133–$0.147 must hold to prevent a deeper retracement. A sustained close above $0.16 and ultimately $0.20 would be required to signal a stronger bullish reversal on the daily timeframe.

    Analyst Outlook and Risk Considerations

    Dogecoin appears to have completed its bearish phase, with exhausted downside momentum and higher-low structure indicating a potential trend reversal toward the next resistance levels at $0.16, $0.173, and $0.185. Source: chart1stry on TradingView

    Forecast ranges for 2025 vary significantly:

    • Evidence-based models: $0.39–$0.73 (trend and volatility forecasts)

    • High-speculation scenarios: $1–$5 (primarily sentiment-driven and lacking strong structural justification)

    Clear risk framing remains essential: DOGE is a high-volatility asset heavily influenced by sentiment, social media cycles, and speculative flows.

    Final Thoughts

    Dogecoin’s near-term technical structure—falling wedge breakout attempts, fractal echoes, and channel formations—suggests that upward continuation could develop if volume confirms and macro conditions align. However, these signals rely on confirmation and remain vulnerable to false breakouts.

    Final Thoughts

    Dogecoin was trading at around $0.15, up 0.90% in the last 24 hours. Source: Brave New Coin

    Based on TradingView and CoinMarketCap data, DOGE trades near $0.15 with a market capitalization of around $23.1 billion and a circulating supply exceeding 151.9 billion coins.

    As always, technical patterns provide scenarios—not guarantees—and should be combined with disciplined risk management.

    Source link

    27 11, 2025

    Gold (XAU/USD) Price Forecast: Bull Pennant Coils – Triple Trendline Resistance Caps

    By |2025-11-27T02:14:13+02:00November 27, 2025|Forex News, News|0 Comments


    Multi-Line Resistance Cluster

    Momentum stayed muted as price met a significant overhead barrier: two separate top ascending trend channel lines plus a short-term downtrend line all converging near today’s high. This triple confluence effectively capped the session and prevented immediate follow-through above the $4,173 area.

    Bull Pennant Development

    Since October’s $4,381 record high, gold has formed a bull pennant—small symmetrical triangle—consolidation pattern. The 20-day average at $4,068, after moving sideways-to-slightly lower since November 4, has now resumed its rise and is closely tracking the internal uptrend line that connects Friday’s slightly higher swing low, creating tight dynamic support.

    Breakout and Confirmation Levels

    The first indication of upside resolution appears on a decisive rally above the short-term downtrend line. A true pennant breakout, however, requires a sustained advance and daily close above the recent lower swing high of $4,245 to confirm continuation of the larger uptrend.

    Underlying Bullish Characteristics

    Consolidation has remained entirely in the top half of the advance and near the upper channel boundaries, reflecting persistent underlying strength. The 50-day average, still untested as support since its late-August reclaim, continues rising below current levels and stands as the ultimate deeper safety net.

    Outlook

    Gold’s higher high/low sequence and confirmed 10-day support keep buyers in command inside the tightening pennant. A decisive close above $4,245 validates upside continuation toward fresh records; persistent failure to clear the triple trendline resistance risks a deeper test of the 20-day/uptrend line confluence near $4,068, with the untested 50-day as final backstop. The long-term bull trend strongly favors eventual upside resolution unless bearish price behavior negates that outlook.

    For a look at all of today’s economic events, check out our economic calendar.



    Source link

    Go to Top